Urologic Pharmacology, An Issue of Urologic Clinics

In this issue ofUrologic Clinics of North America,guesteditorDr.Craig V.Comiterbringshisconsiderable expertise to the topic ofUrologic Pharmacology.Medical therapies for benign prostatic hyperplasia, erectile dysfunction, hypogonadism, overactive bladder, and prostate cancer are widely available, and a basic understanding of the pharmacology of existing treatment options are necessary to avoid complications and maximize efficacy associated with patient outcomes. In this issue,top experts in the fieldprovide current clinical information to help urologists effectively and quickly treat patients. Contains14relevant, practice-oriented topicsincludingmedical treatment for benign prostatic hyperplasia, medical treatment for urinary tract infections,nutraceuticalsand phytotherapy in men's health, hormonal therapy for prostate cancer, medical treatment of female sexual dysfunction,and more. Provides in-depthclinical reviews onurologic pharmacology,offeringactionable insights for clinical practice. Presents thelatest information on this timely, focused topicunder the leadership of experienced editors in the field.Authors synthesize and distill the latest research and practice guidelines to createclinically significant,topic-based reviews.